TY - JOUR
T1 - EBI2 contributes to the induction of thymic central tolerance in mice by promoting rapid motility of medullary thymocytes
AU - Ki, Sanghee
AU - Thyagarajan, Hiran M.
AU - Hu, Zicheng
AU - Lancaster, Jessica N.
AU - Ehrlich, Lauren I.R.
N1 - Funding Information:
Acknowledgments: We thank Jason Cyster for provision of Ebi2−/− mice and for helpful suggestions, Hilary Selden for technical assistance, Ellen Richie for helpful suggestions, and the staff of the UT Austin animal facility for assistance with mice. This work was supported by grants from the National Institutes of Health (R01AI104870 to L.I.R.E.) and the Cancer Prevention Research Institute of Texas (R1003 to L.I.R.E.) Conflict of interest: The authors declare no commercial or financial conflict of interest.
Publisher Copyright:
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2017/11
Y1 - 2017/11
N2 - Maturing thymocytes enter the thymic medulla, where they encounter numerous self-antigens presented by antigen presenting cells (APCs). Those thymocytes that are strongly self-reactive undergo either negative selection or diversion into the regulatory T-cell lineage. Although the majority of the proteome is expressed in the medulla, many self-antigens are expressed by only a minor fraction of medullary APCs; thus, thymocytes must efficiently enter the medulla and scan APCs to ensure central tolerance. Chemokine receptors promote lymphocyte migration, organization within tissues, and interactions with APCs in lymphoid organs. The chemokine receptor EBI2 governs localization of T cells, B cells, and dendritic cells (DCs) during immune responses in secondary lymphoid organs. However, the role of EBI2 in thymocyte development has not been elucidated. Here, we demonstrate that EBI2 is expressed by murine CD4+ single positive (CD4SP) thymocytes and thymic DCs. EBI2 deficiency alters the TCR repertoire, but does not grossly impact thymocyte cellularity or subset distribution. EBI2 deficiency also impairs negative selection of OT-II TCR transgenic thymocytes responding to an endogenous self-antigen. Two-photon imaging revealed that EBI2 deficiency results in reduced migration and impaired medullary accumulation of CD4SP thymocytes. These data identify a role for EBI2 in promoting efficient thymic central tolerance.
AB - Maturing thymocytes enter the thymic medulla, where they encounter numerous self-antigens presented by antigen presenting cells (APCs). Those thymocytes that are strongly self-reactive undergo either negative selection or diversion into the regulatory T-cell lineage. Although the majority of the proteome is expressed in the medulla, many self-antigens are expressed by only a minor fraction of medullary APCs; thus, thymocytes must efficiently enter the medulla and scan APCs to ensure central tolerance. Chemokine receptors promote lymphocyte migration, organization within tissues, and interactions with APCs in lymphoid organs. The chemokine receptor EBI2 governs localization of T cells, B cells, and dendritic cells (DCs) during immune responses in secondary lymphoid organs. However, the role of EBI2 in thymocyte development has not been elucidated. Here, we demonstrate that EBI2 is expressed by murine CD4+ single positive (CD4SP) thymocytes and thymic DCs. EBI2 deficiency alters the TCR repertoire, but does not grossly impact thymocyte cellularity or subset distribution. EBI2 deficiency also impairs negative selection of OT-II TCR transgenic thymocytes responding to an endogenous self-antigen. Two-photon imaging revealed that EBI2 deficiency results in reduced migration and impaired medullary accumulation of CD4SP thymocytes. These data identify a role for EBI2 in promoting efficient thymic central tolerance.
KW - 2-photon
KW - Central tolerance
KW - EBI2
KW - Negative selection
KW - Thymocyte motility
KW - Thymus
KW - Treg cell differentiation
UR - http://www.scopus.com/inward/record.url?scp=85032896506&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032896506&partnerID=8YFLogxK
U2 - 10.1002/eji.201747020
DO - 10.1002/eji.201747020
M3 - Article
C2 - 28741728
AN - SCOPUS:85032896506
SN - 0014-2980
VL - 47
SP - 1906
EP - 1917
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 11
ER -